Lilienfeld's Foundations of Epidemiology (Revised) - Schneider, Dona (Professor and Associate Dean in the Edward J. Blous; Lilienfeld, David E. (Principal, Principal, Write for the Pharm, LLC
62,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 1-2 Wochen
payback
31 °P sammeln
  • Broschiertes Buch

Two decades after the third edition of Lilienfeld's Foundations of Epidemiology advanced the teaching of epidemiology, this completely revised fourth edition offers a new and innovative approach for future generations of students in population health.

Andere Kunden interessierten sich auch für
Produktbeschreibung
Two decades after the third edition of Lilienfeld's Foundations of Epidemiology advanced the teaching of epidemiology, this completely revised fourth edition offers a new and innovative approach for future generations of students in population health.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
Dona Schneider, PhD, MPH, is Professor and Associate Dean in the Edward J. Bloustein School of Planning and Public Policy at Rutgers University, where she has taught medical geography and epidemiology to undergraduate and graduates students for more than 25 years. Her research record includes more than 125 refereed journal articles, books and book chapters, mostly focusing on mortality, morbidity and risk factors for disease, especially for children and minorities. David E. Lilienfeld, MD, MPH, MBA, is an internationally recognized expert and educator in epidemiology and public health history. He was a pioneering figure in the area of pharmacoepidemiology and has made many contributions across the spectrum of epidemiologic inquiry. Dr. Lilienfeld has held leadership roles in the establishment and growth of many of the professional societies in the epidemiology community, and has also served in an editorial capacity for several epidemiology journals. In addition to his scholarly endeavors, Dr. Lilienfeld has been a strong advocate for epidemiology within the pharmaceutical industry and he co-developed (with Bert Black) the template for the use of epidemiologic evidence in legal proceedings.